Skip to content

Validation and Evaluation of the Mastication Function in Adults: The Functional Six-minute Mastication Test (F-6MMT).

Validation and Evaluation of the Mastication Function in Adults: The Functional Six-minute Mastication Test (F-6MMT).

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06298786
Acronym
F-6MMT
Enrollment
514
Registered
2024-03-07
Start date
2025-09-30
Completion date
2026-04-30
Last updated
2025-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chewing Problem, Fatigue, Mastication Disorder, Orofacial Pain, Temporomandibular Disorder

Brief summary

Temporomandibular Disorders (TMD) encompass various conditions that affect the temporomandibular joint and associated tissues, often causing or being associated with other symptoms such as jaw pain, myofascial pain, neck pain, and headaches. TMDs are classified according to the DC/TMD instrument in which the joint and pain axes are evaluated. However, there is no evaluation of mandibular function, and TMDs can result in a decrease in jaw strength and resistance. This leads to an increase in the chewing fatigue. Reliable and time-effective diagnostic methods for evaluating masticatory function are crucial in the clinical setting because of the high prevalence of TMD. Chewing efficiency is essential for food preparation and nutrient absorption, and muscle fatigue is a common problem affecting chewing ability. Despite this, there is a lack of validated tests to evaluate chewing fatigue in patients with TMD, which makes its consideration unnoticed in clinical practice. The modified six-minute functional chewing test (F-6MMT) was proposed as a tool to evaluate chewing ability and fatigue in patients with TMD. This test is an adaptation of a previously designed test in which subjects with mitochondrial pathology were evaluated; however, the subjects were not instructed to perform functional chewing during the test. In this version, modifications are added so that the test is as functional as possible, allowing chewing to be evaluated in a standardized way, and cut-off points established between healthy subjects and subjects with TMD in terms of chewing capacity in general and fatigue in particular. This study will follow standardized reporting guidelines and recruit participants from diverse clinical settings.

Interventions

DIAGNOSTIC_TESTFunctional 6-minute mastication test

All participants will be evaluated in 3 different phases. First, they will respond to the online TMD screener questionnaire. Then, they will be presentally evaluated using the DC/TMD and finally they will undergo the functional 6-minute mastication test.

Sponsors

Universitat Internacional de Catalunya
CollaboratorOTHER
Fundació Universitària del Bages
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women and men of legal age * With or without TMDs symptoms and * With or without self-reported jaw fatigue when eating

Exclusion criteria

* Subjects treated with any type of treatment requiring infiltration of the mandibular region * Participants undergoing dental interventions in the last 3 months * Individuals missing two or more teeth in the same quadrant. * Inability to understand or speak catalan, spanish or english.

Design outcomes

Primary

MeasureTime frameDescription
FatigueImmediately before the procedure, immediately after the procedure, and five minutes after the procedureScore fatigue on a Numerical Rating Scale (0-10). 0 means no fatigue and 10 the highest fatigue possible.
Self-reported PainImmediately before the procedure, immediately after the procedure, and five minutes after the procedureScore pain on a Numerical Rating Scale (0-10). 0 means no pain and 10 the highest pain possible
Sensitivity and Specificitythrough study completion, an average of 1 yearAbility to identificate cases vs controls
Feasibitythrough study completion, an average of 1 yearIntra and inter examinator feasibility
ReplicabilityThrough study completion, an average of 1 yearConsistency and precision of the test

Secondary

MeasureTime frameDescription
Kinesiofobia related to TMDBefore the procedureQuestionnaire TSK-TMD. Score from 12 to 48 points
Pain-related TMD diagnosisBefore the procedureAll subjects will be classified into the following categories according to the diagnostic criteria for temporomandibular disorders: i) positive TMD (TMD-P), ii) arthralgia (TMD-A), iii) local myalgia (TMD-LM), iv) myofascial pain (TMD-MP), v) headache attributed to TMDs (TMD-HA) or vi) negative TMD (TMD-N)
ComorbiditiesBefore the procedureCentral Sensitization Inventory. Score from 0 to 125 and a checklist
Health statusBefore the procedurePatient Health Questionnaire-4 (PHQ-4). Score from 0 to 12.
Self-reported daily fatigueBaselineDichotomous answers (YES/NO) from the question: Do you feel tension, heaviness, tiredness, or fatigue of the jaw muscles in any of the daily activities such as chewing, eating, swallowing, smiling, kissing, gesturing, smiling, singing or yawning?
Pain pressure threshold (PPT)Immediately before the procedure, immediately after the procedure, and five minutes after the procedureFor measuring PPT a digital algometer (Baoshinshan), with a precision ± 0,2% and a metallic extremity of one cm2 will be used at masseter, anterior temporalis, and forearm of both sides. Scores of the PPT will be measured as Kg/cm\^2
Taste of the gumImmediately after the procedureScore taste on a Numerical Rating Scale (0-10). 0 means not tasty, and 10 absolutely tasty.
Preferred side when chewing during the F-6MMTImmediately after the procedureScore how easy was to chew the gum for each side. Numerical Rating Scale (0-10). 0 means preferred left side, 5 means balanced, and 10 preferred right side.

Countries

Spain

Contacts

Primary ContactJordi Padrós-Augé, Mr
jpadros@umanresa.cat+34613040826
Backup ContactArnau Cerdà-Ribó, Mr.
acerda@umanresa.cat+34672726921

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026